Background: Gut hormones and their receptors are considered important in the control of feeding behavior. The gut hormone peptide-YY (PYY) has anorexic effects via the inhibitory neuropeptide Y2 receptor (Y2R) highly expressed in orexigenic NPY/ AGRP neurons within the arcuate nucleus, a major integrator of appetite control in the hypothalamus. Design: Genetic case-control association study of single nucleotide polymorphisms (SNPs) in Y2R and PYY. Subjects: Swedish Caucasians comprising 148 lean, 129 overweight/obese and 226 morbidly obese men. Measurements: Genotypes of the common, silent and conserved SNP Y2R 585T4C and the common SNP PYY Arg72Thr, as well as various obesity-related clinical parameters. Results: Obese men had a lower allele and homozygosity frequency of the common allele 585T4C:T which was particularly evident comparing morbidly obese with lean men (P ¼ 0.002), and analyzing dependence between continuous body mass index (BMI) and genotype (P ¼ 0.002). In agreement, systolic blood pressure tended to be lower in those homozygous for allele T, which was not explained by the BMI -genotype dependence. We found no association to obesity for the PYY Arg72Thr polymorphism, which is located nearby the essential carboxy terminal. Conclusion: A common and conserved variant of the PYY and NPY receptor Y2R is less prevalent among obese compared to among lean Swedish men. This suggests that the common Y2R variant is protective against obesity. Our findings further implicate Y2R in food intake regulation.
Introduction
Obesity is a profound health and socio-economic burden. 1 Family, twin and adoption studies have reported estimates of heritability for body mass index (BMI) to be between 50 and 90%, 2 demonstrating a principal role for genetic factors in determining body weight (reviewed in Friedman 3 ). These factors are gene variations that affect the balance between energy intake and expenditure. Gut hormones and their receptors are considered to play an important role in the control of feeding behavior (reviewed in Small and Bloom 4 and Wynne et al. 5 ). The gut hormone peptide-YY (PYY), 6 which belongs to the pancreatic polypeptide (PP) family together with neuropeptide Y (NPY) and PP, has been reported to reduce food intake in both rodents and humans. 7, 8 PYY 1À36 is secreted by cells localized in distal small intestine and colon in response, and in proportion, to the calorie content of a meal. 9 Cleavage by the enzyme dipeptidyl-peptidase IV yields the circulating form most abundant after a meal, PYY . 10, 11 In the fasting state, PYY is the dominating form. 9 While PYY and NPY 12 can activate NPY receptors Y1, Y2 and Y5, PYY 3-36 is a selective agonist for the Y2 receptor. 13 Y2R is a seven transmembrane domain G-protein-coupled presynaptic inhibitory autoreceptor, 14 which is highly expressed in NPY neurons within the hypothalamic arcuate nucleus, a key brain area regulating appetite. 15 Peripheral and intra-arcuate administration of PYY in rodents inhibits food intake. 7, 8, 16 However, PYY had no effects on food intake in Y2R knockout mice. 7 Studies in humans showed that peripheral infusion of postprandial level of PYY into normal and obese subjects decreased the caloric intake at a buffet meal by over 30% in both groups. 7, 17 The fasting PYY levels and postprandial PYY release were lower in obese compared to lean individuals. 17 Recently, 101 patients with severe early-onset obesity in the UK were screened for mutations in the PYY and the Y2R genes. 18 Two PYY SNPs common among both obese and control individuals, and in linkage disequilibrium (LD) with each other, were identified, one being Arg72Thr. Arg72Thr is located five residues downstream of the proteolysis-amidation site essential for proper C-terminal processing to mature PYY. 19 Similarly, two common SNPs, in close LD with each other, were found within Y2R, one being synonymous Y2R 585T4C encoding 195Ile which is located within the third extracellular domain of Y2R. The PYY Arg72Thr and the Y2R 585T4C SNPs were analyzed for association with obesityrelated variables in a cross-sectional sample of the eastern England population where 90% were Caucasian and the BMI mean was 26.6 kg/m 2 . A small effect of Y2R 585T4C genotype on BMI, waist-hip ratio and fatty acid level was found among men. However, no association was found between the PYY Arg72Thr and obesity-related phenotypes. 18 Based on the reports of PYY having an influence on food intake, and the Y2R association finding by Hung et al., 18 we hypothesized that the potentially functional PYY variation Arg72Thr and the BMI-associated Y2R variation 585T4C segregating in the human population would influence BMI variation in a Swedish male population. By using a case-control design where cases were those referred to hospital care for uncomplicated obesity, that is a sample enriched for primarily morbid obesity, we hypothesized to have a higher probability to detect PYY association and to find stronger effect of Y2R on obesity as compared to Hung et al. 18 Moreover, since the Swedish subjects were characterized for more obesity-related parameters than the English, this study would possibly provide a more complete picture of potential obesity association with PYY Arg72Thr and Y2R 585T4C. , morbidly obese group). None of these individuals had other known metabolic disorder including diabetes, familial combined hyperlipidemia, polycystic ovary disease, cancer or thyroid disturbance. Also, Type 2 diabetes (T2DM) patients comprising 62 obese and five lean men were included. None of the individuals was completely sedentary, involved in athletic performance or had undertaken any weight-reduction effort during the last 6 months. After an overnight fast they were examined for the clinical metabolic parameters: BMI, body fat mass (BFM, determined by bioimpedance (Model TBF305, Tanita Corporation, Tokyo, Japan)), waist/hip ratio (supine position), systolic and diastolic blood pressure (SBP, DBP, supine position) and plasma levels of glucose, insulin, triglycerides, cholesterol and HDL-cholesterol. Plasma variables were measured by the hospital's accredited routine chemistry laboratory. The distributions of age and the clinical parameters of the men without T2DM are given in Table 1 . The study was explained in detail to each participant. All subjects gave informed consent to participate in the study. The study was approved by the Ethics Committee of Karolinska University Hospital Huddinge.
Material and methods

Subjects
Genotyping
The following single nucleotide polymorphisms (SNPs) were studied: PYY Arg72Thr (dbSNP rs ID rs1058046, G4C (www.ncbi.nlm.nih.gov/projects/SNP/)), and Y2R 585T4C (rs1047214, Ile195Ile, 585 refers to nucleotide position after translation initiator). PCR conditions included 0.25 ng/ml DNA, 0.2 mM of each primer, 50 ml total volume and 45-50 temperature cycles at 601C annealing temperature. Forward and reverse primer sequences were for rs1058046 Biotin (B)-5 0 -CACTACCTCAACCTGGTC-3 0 and 5 0 -TGATGTTGCCAGG GTAGG-3 0 ; and for rs1047214 B-0 5 0 -TGATTATTGGCTTGGC CTGG-3 0 and 5 0 -CTGTCAATGTCAACGGCAAG-3 0 . Each 96-well PCR plate contained at least one negative control (no template). In each plate, eight PCR products including a negative control were size controlled by gel electrophoresis.
The PCR products were prepared for Pyrosequencingt (PSQt) using streptavidin-coated sepharose beads and the Vacuum Prep Tool (Biotage AB, Uppsala, Sweden), and the PSQt reactions were performed on a PSQ96MAt instrument using the PSQ96t SNP reagent kit (Biotage AB), both steps according to manufacturer's instructions. The sequencing primers were for rs1058046 5 0 -AGAACGTTTTGGAAAGA AGC-3 0 , and for rs1047214 5 0 -GCCACAATCTCAAAGTCC GG-3 0 . The PSQ96t plates contained the same sample sets as the PCR plates, including the negative controls.
Statistical analysis
Hardy-Weinberg equilibrium test was applied on the nonobese and obese men separately to ensure independent segregation of alleles. 20 
Bioinformatics
Nucleotide homology searches were performed to detect putative genes in the vicinity of Y2R. The sequence between 18 kb upstream and 4 kb downstream Y2R was searched using BLASTX 21 towards the Uniprot/Swissprot database. 22 We also translated the nucleotide sequence into all six reading frames using sixpack from the EMBOSS suite. 23 Detected open reading frames encoding peptides longer than 100 amino-acid residues were analyzed for homology with proteins in the UniProt/Swissprot database.
Results
The silent SNP 585T4C, encoding 195Ile located within the third extracellular domain of Y2R, and the non-synonymous PYY variation Arg72Thr, located five residues downstream of the C-terminal of mature PYY, were analyzed for association with obesity among 503 Swedish men. 585T4C and Arg72Thr were successfully genotyped in 95 and 91% of the samples, respectively. Allele frequencies of the SNPs were in Hardy-Weinberg equilibrium. We found an association between the 585T4C SNP and obesity. The Obese men had a lower frequency of the common allele 585T4C:T compared to the lean men (w 2 ¼ 7.2, 2 d.f., P ¼ 0.026). The difference was even more pronounced when comparing the morbidly obese with the lean group 1d.f., P ¼ 0.007 (Table 2) . Likewise, the 585T4C genotype distribution differed between morbidly obese, overweight/obese and lean (w 2 ¼ 10.8, 4 d.f., P ¼ 0.029), and more evidently comparing the morbidly obese with the lean group (w 2 ¼ 9.8, 2 d.f., P ¼ 0.007). This was explained by lower frequency of homozygosity for the common allele T among the morbidly obese men (OR ¼ 1.8, Table 3 ). In agreement, in the combined sample of 503 men BMI was lower among men with 585T4C T/T genotype (P ¼ 0.0073 comparing three genotypes, and P ¼ 0.0018 comparing T/T with T/C þ C/C, Kruskal-Wallis test, Table 4 ). Likewise, men with T/T genotype had a lower SBP (F ¼ 3.8, 2 d.f., P ¼ 0.024 comparing the three genotypes; F ¼ 6.7, 1 d.f., P ¼ 0.010 comparing T/T with T/C þ C/C, ANOVA with age as predictor, Table 4 ). Also, they had lower DBP (F ¼ 2.54, 2 d.f., P ¼ 0.080 comparing the three genotypes; F ¼ 5.0, 1 d.f., P ¼ 0.026 comparing T/T with T/C þ C/C, ANOVA with age as predictor, Table 4 ). Furthermore, there was a tendency for plasma triglycerides and insulin to be lower among men with T/T genotype (P ¼ 0.063, ANOVA with age as predictor, Table 4 ). The association with SBP tended to be partially independent of Neuropeptide Y2 receptor gene variant and obesity C Lavebratt et al BMI (P ¼ 0.062, ANOVA having both age and BMI as predictors). The 585T4C associations with DBP, triglycerides and insulin were dependent on BMI (P40.15, ANOVA having both age and BMI as predictors). After inclusion of data from men with T2DM, 62 overweight or obese and five lean, the leanness -585T4C association still held (Table 3) . Neuropeptide Y2 receptor gene variant and obesity C Lavebratt et al
No association was found between PYY Arg72Thr and obesity or related parameters (Tables 2 and 3) .
There was a difference in age distribution between the lean and the obese groups (P ¼ 0.005, Kruskal-Wallis test, Table 1 ). However, there was no association between age and Y2R 585T4C or PYY Arg72Thr genotype (P ¼ 0.55 and 0.85, respectively, ANOVA). Also, the positive findings were supported by tests where age was controlled for.
Discussion
We here report association between the NPY2 receptor (Y2R) and obesity among 503 Swedish men. Obese men had a lower allele and homozygosity frequency of the common allele 585T4C:T which was particularly evident comparing morbidly obese with lean men (P ¼ 0.007 and 0.002, respectively), and analyzing dependence between BMI and genotype (P ¼ 0.002). In agreement, there was lower SBP and DBP pressure, and a tendency for lower plasma triglyceride and insulin levels in those homozygous for allele T. For BFM there was only a weak tendency for being lower in those having the T/T genotype, which might be explained by the fact that BFM data were available from only 262 of the 503 men. The 585T4C:T/T association with SBP was not fully explained by the BMI -genotype dependence. Mean age was 4 years higher in the morbidly obese group compared to in the lean group. In the test for association with BMI age was not possible to adjust for due to non-normal BMI distribution. However, since age was similar for all 585T4C genotypes, age was excluded as a considerable confounder of the BMI-585T4C association.
In support of the candidature of Y2R gene in predisposing obesity, this receptor has two agonists which both are known to regulate appetite, PYY and NPY. 8, 12, 24 Y2R is highly expressed in the arcuate nucleus, a major integrator of appetite control in the hypothalamus, but also in other hypothalamic areas, dorsal root ganglia, hippocampus, as well as in peripheral neurons, the intestine and certain blood vessels. [25] [26] [27] [28] Y2R mediates presynaptic actions involving suppression of neurotransmitter release 29 through inhibition of adenylyl activation via Gi. 25 It is expressed mainly in orexigenic NPY/AGRP neurons 15 which, in direct synaptic contact with anorectic POMC/CART neurons in the arcuate nucleus, 30 integrates gut hormone signals such as PYY . 31, 32 Hence, Y2R mediates negative regulation of NPY signaling, and indirectly upregulation of POMC/CART, through PYY 3-36 and NPY. 7 Peripheral administration of PYY in rodents reduces NPY mRNA levels and increases the POMC mRNA levels in the arcuate nucleus, as well as reduces food intake, but has no effect in fasted Y2R knockout mice. 7, 16 However, there are redundancy or compensatory mechanisms as reflected by slightly increased body weight and generally larger food intake in full, and conditional hypothalamic, Y2R knock-out mice 33, 34 and by results from studies on other NPY receptor knockouts. 35 Hung et al. 18 recently reported association for Y2R 585T4C polymorphism to obesity-related parameters among 421 men representing the general population in eastern UK. However, they found homozygosity for the rare allele C, and not the common allele T, to be associated with lower BMI, lower waist-hip ratio and higher fasting non-esterified fatty acid level. The discrepancy between the results from our study and that of Hung et al. 18 SBP tended to be associated with Y2R 585T4C, independently of BMI. This is an interesting observation in light of the fact that the Y2R agonist NPY is localized in various neurons innervating the heart, blood vessels as well as brain areas controlling cardiovascular function. NPY has been shown to increase vasoconstriction and heart rate as a consequence of high sympathetic activity. This results from Y2R-mediated inhibition of parasympathetic neurotransmission. [36] [37] [38] The functional polymorphism reflected by the Y2R association is likely in LD with 585T4C. 585T4C is silent and not within any putative exonic splicing enhancer site. 39 However, the T variant of 585T4C is highly conserved among mammals, with only pig (has allele C) among nine mammals having other allele (NCBI, February 2005). The only common silent SNP (rs2880415) in high LD with 585T4C among British Caucasians 18 was neither in a putative exonic splicing site nor conserved among mammals. There is no non-synonymous SNP within Y2R, but several SNPs in the intron or intergenically. Thus, the functional polymorphism might regulate transcription or splicing. Its position within another gene is unlikely since no other gene was found within an interval from 18 kb upstream to 4 kb downstream Y2R. Hung et al. 18 found no Y2R 585T4C association with obesity in women. Gender-specific effects of genetic variation on measures of body mass and composition have been repeatedly demonstrated in several different gene studies. 40 Y2R, which is the selected receptor for PYY , has stringent demands on the C-terminal part of its agonists, and amidation is an obligate requirement. 19 PYY Arg72Thr lies only five amino acids downstream the carboxy-terminal cleavage and amidation site. However, it is not highly conserved, nine of 15 mammals are reported with only Thr (NCBI, 2005) , and the likelihood of it to be a putative exonic splicing site was similar for the two alleles. 39 Association with obesity-related parameters was found for the PYY Arg72Thr neither in our nor in the study by Hung et al.
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In summary, we report that the frequent allele of a common, silent and conserved SNP of the PYY and NPY receptor Y2 is less prevalent among obese compared to among lean Swedish men. This suggests that the common Y2R variant is protective against obesity. This adds further evidence to the hypothesis that Y2R is implicated in food intake regulation. If the same holds true for women or other ethnic populations remains to be established.
